NRX Pharmaceuticals
NRXP
NRXP
34 hedge funds and large institutions have $25.1M invested in NRX Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
11% less funds holding
Funds holding: 38 → 34 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Holders
34
Holding in Top 10
–
Calls
$1.34M
Puts
$1.05M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$1.92M | |
| 3 | +$1.53M | |
| 4 |
Renaissance Technologies
New York
|
+$341K |
| 5 |
State Street
Boston,
Massachusetts
|
+$255K |
Top Sellers
| 1 | -$294K | |
| 2 | -$257K | |
| 3 | -$237K | |
| 4 |
Squarepoint
New York
|
-$141K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$135K |